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Abstract Ubiquinone (UQ) (coenzyme Q) is a lipophilic redox-
active molecule that functions as an electron carrier in the
mitochondrial electron transport chain. Electron transfer via UQ
involves the formation of semiubiquinone radicals, which causes
the generation of superoxide radicals upon reaction with oxygen.
In the reduced form, UQ functions as a lipid-soluble antioxidant,
and protects cells from lipid peroxidation. Thus, UQ is also
important as a lipophilic regulator of oxidative stress. Recently,
a study on long-lived clk-1 mutants of Caenorhabditis elegans
demonstrated that biosynthesis of UQ is dramatically altered in
mutant mitochondria. Demethoxy ubiquinone (DMQ), that
accumulates in clk-1 mutants in place of UQ, may contribute
to the extension of life span. Here we elucidate the possible
mechanisms of life span extension in clk-1 mutants, with
particular emphasis on the electrochemical property of DMQ.
Recent findings on the biochemical function of CLK-1 are also
discussed. ß 2002 Published by Elsevier Science B.V. on be-
half of the Federation of European Biochemical Societies.
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1. Introduction
Caenorhabditis elegans is one of the most extensively used
model organisms in elucidating the mechanisms of life span
regulation [1]. Some of the biological pathways implicated in
ageing have been identi¢ed from the study of various long-
and short-lived mutant strains [2,3]. Studies of a group of
long-lived mutants that includes mutants in the daf-2, age-1,
and daf-16 genes revealed that life span is a¡ected by an in-
sulin-receptor-like signaling cascade that also a¡ects the for-
mation of dormant dauer larvae [4,5]. The mechanism of life
span extension by this signaling pathway is under intense
study [1]. Another group of long-lived mutants include eat
mutants, which are de¢cient in food uptake [6]. Life span
extension in eat mutants possibly results from restricted calo-
ric intake [7], as observed in other organisms [8]. It has been
suggested that these phenomena are linked to the generation
of reactive oxygen species (ROS), which is believed to be one
of the causes of ageing [8].
clk-1 mutants were identi¢ed as long-lived strains, which
also exhibit a slow-down in developmental and behavioral
rates, including the cell cycle, development, and rhythmic
adult behaviors [9]. The biological pathway altered in clk-1
mutants appears to be distinct from that of the insulin-recep-
tor-like signaling cascade, since the life span of daf-2, clk-1
double mutants is several times longer than that of either clk-1
or daf-2 mutants [7]. The observation that eat-2, clk-1 double
mutants do not further increase life span [7], raised the pos-
sibility that the biological pathways that are altered by clk-1
and eat-2 mutations may overlap. However, until recently,
neither the biochemical alteration in clk-1 mutants nor the
exact function of the CLK-1 protein were known (reviewed
in [2,10^13]). Recently, we [14], and others [15] demonstrated
that clk-1 mutants do not contain ubiquinone (UQ). We
showed instead that the mutants accumulate a biosynthesis
intermediate, demethoxy ubiquinone (DMQ) [14] (Fig. 1).
These ¢ndings indicate that quinones have a critical role in
the process that regulates life span. In this minireview, we
consider the possible mechanism of life span extension in
clk-1 mutants. Particular focus is on the electrochemical prop-
erty of the UQ biosynthesis intermediate, DMQ, as this may
reveal the property of quinones that is critical in the process
of ageing.
2. Quinone composition in long-lived clk-1 mutant
UQ is a lipophilic, redox-active molecule (Fig. 1), and func-
tions as an electron carrier in the mitochondrial respiratory
chain. UQ is reduced at complex I (NADH-UQ reductase)
and complex II (succinate-UQ reductase). Reduced UQ
(UQred) then transfers electrons to complex III (ubiquinol-cy-
tochrome c reductase), which regenerates oxidized UQ
(UQox). Electron transfer via UQ is an essential step in oxi-
dative phosphorylation by the respiratory chain. Not surpris-
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ingly, UQ de¢ciency in humans has been found to be associ-
ated with severe mitochondrial encephalomyopathy [16,17].
The biosynthesis pathway of UQ has been extensively ana-
lyzed in Escherichia coli [18] and Saccharomyces cerevisiae
[19]. Fig. 1 shows the steps involved in the aromatic ring
formation in the UQ biosynthesis pathway. Part of the bio-
synthesis steps from 4-hydroxy-3-polyprenylbenzoic acid
(compound 1 in Fig. 1) to 2-polyprenyl-6-methoxyphenol
(compound 6 in Fig. 1) is considered to be di¡erent between
E. coli and yeast [18,19]. It has been proposed that, in mam-
mals, the order of these steps is the same as in E. coli [20,21].
However, none of the enzymes catalyzing the reactions in Fig.
1 have yet been puri¢ed from any organism, and little is
known about their enzymatic properties. The factors regulat-
ing biosynthesis and the localization of UQ to various cellular
membranes also remain to be uncovered.
DMQ is one of the biosynthesis intermediates of UQ (Fig.
1). In clk-1 mutant mitochondria, DMQ9 (numbers indicate
the isoprenoid side chain length) is accumulated to the same
level as UQ9 in wild-type mitochondria [14]. Interestingly,
DMQ9 supports respiration of clk-1 mutant mitochondria to
a considerable degree [14]. This ¢nding is consistent with the
observation that oxygen consumption is not severely deterio-
rated in clk-1 mutants [22], and indicates that DMQ is a
redox-active molecule. While DMQ2 accepts electrons from
complex I at the same rate as UQ2, electron transfer from
complex II to DMQ2 was slightly reduced [14]. A similar
observation in E. coli ubiF mutant [23] and in mouse mclk1
knockout mutants [24], which also contain DMQ instead of
UQ, indicates that the structure and the mid-point potential
of DMQ might be more favorable to function as an electron
acceptor at complex I than at complex II. On the other hand,
3-hydroxy UQ2 (2-methoxy-3-hydroxy-5-methyl-6-geranyl-
1,4-benzoquinone; compound 9 in Fig. 1) does not support
the electron transfer neither from complex I nor from complex
II [14]. From these ¢ndings it is clear that not all the UQ
biosynthesis intermediates can function as electron carriers
in the respiratory chain.
3. Role of quinones as pro- and antioxidant
One of the functions of UQ is to transfer electrons in the
respiratory chain, which generates the proton motive force
across the inner mitochondrial membrane for oxidative phos-
phorylation. However, electron transfer in the respiratory
chain is also accompanied by the generation of ROS [25,26].
This event is most likely to occur via the formation of a by-
product of UQred oxidation, semiubiquinone radicals (UQsem)
at complex III [25], in which UQred undergoes single electron
oxidation/reduction by the proton motive Q-cycle [27]. UQsem
is highly reactive to molecular oxygen and generates super-
oxide radicals [25,26], which are toxic to proteins, especially to
those containing iron^sulfur clusters [28]. Furthermore, the
formation of superoxide results in the generation of its dis-
mutated product, hydrogen peroxide, from which hydroxyl
radical can be formed [26]. These ROS cause extensive oxida-
tive damage to biological macromolecules, a process that
likely is an important factor in aging [8,29,30].
Contrary to this prooxidant activity of UQsem, UQred has
been regarded as a lipid-soluble antioxidant [31,32]. This no-
tion is supported by the fact that yeast strains de¢cient in UQ
biosynthesis show increased sensitivity to the products of au-
Fig. 1. UQ biosynthesis pathway proposed from the genetic studies of E. coli [18] and S. cerevisiae [19]. Compounds indicated in this ¢gure
are: 1, 4-hydroxy-3-polyprenylbenzoic acid; 2, 2-polyprenylphenol; 3, 2-hydroxy-6-polyprenylphenol; 4, 3,4-dihydroxy-5-polyprenylbenzoic
acid; 5, 4-hydroxy-3-methoxy-5-polyprenylbenzoic acid; 6, 2-methoxy-6-polyprenylphenol; 7, 2-methoxy-6-polyprenyl-1,4-benzoquinol; 8, DMQ;
9, 3-hydroxy UQ; 10, UQ. C. elegans clk-1 mutants accumulate DMQ9 [14]. Yeast coq7 deletion mutant accumulates compound 1, and coq7
missense mutant (coq7-1) contains DMQ6 [60].
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tooxidized polyunsaturated fatty acids [33]. The maintenance
of UQred level is possibly achieved partly by DT-diaphorase
and cytosolic NADPH-quinone reductase [34,35], in addition
to the reduction by the respiratory chain. It has been shown
that UQred is capable of reducing fatty acid radicals either
directly [36,37], or indirectly via regeneration of K-tocopherol
[31,38^40]. This antioxidative action of UQred exerts bene¢cial
e¡ects for the treatment of cardiomyopathy and the recovery
from ischemia, as well as the protection of neuronal cells [41^
43]. In fact, the serum UQred/UQox ratio can be used as a
reliable index to estimate the level of oxidative stress [44].
However, it has been also known that UQsem, which is pro-
duced as the result of radical scavenging action of UQred, is
prooxidative, and causes the production of superoxide and
lipid peroxidation [45]. It is presently unproven how the rad-
ical chain reaction derived from UQsem is quenched, to main-
tain the net antioxidant action of UQred.
Considering these properties of quinones, and the fact that
the primal cause of the ROS generation is the autooxidation
of Qsem by the interaction with oxygen [46], the important
parameter in evaluating the pro-/antioxidant action of qui-
nones would be the reactivity of various quinones toward
oxygen. We have therefore examined whether these parame-
ters are distinct between UQsem and DMQsem, to get insight
into the possible mechanism of life span extension in clk-1
mutants.
4. Electrochemical properties of DMQ
The redox and catalytic properties of quinones for oxygen
reduction can be evaluated from cyclic voltammetry of qui-
none-modi¢ed electrodes. UQ2 and DMQ2 adsorb on a glassy
carbon electrode to form a monolayer. The UQ2- and DMQ2-
modi¢ed electrodes gave a couple of reduction and oxidation
wave under anaerobic conditions. The electrode reaction is
written by [47]:
Qox 3
e3
Qsem 3
e32H
Qred 1
The formal redox potential (E‡P) was evaluated as 85 mV
and 68 mV vs. SHE (standard hydrogen electrode) for UQ2
and DMQ2, respectively, at pH 7.0 (Kano, unpublished data).
The observed lower E‡P of DMQ2 compared with UQ2 partly
explains why DMQ2 accepts electrons more e⁄ciently from
complex I (NADH/NAD ; 3320 mV) than from complex II
(succinate/fumarate; +30 mV).
Under O2-saturated conditions, the voltammogram exhib-
ited the catalytic reduction current around E‡P. The predom-
inant reaction is the catalytic reduction of O2 by Qsem to
generate Oc32 , as written by [48]:
Qsem O2 ! Qox Oc32 2
Qox  e3 ! Qsem 10
At potentials more negative than E‡P of the quinones where
Qred is the predominant species, no signi¢cant catalytic e¡ect
was observed. The result clearly evidences that Qsem is much
more susceptible to the autooxidation than Qred. The electric-
ity in the background-subtracted catalytic cathodic wave
(Qcat) is reasonably attributable to the reduction of O2 as
well as the adsorbed quinone, while that of the cathodic wave
under anaerobic conditions (QQ) is attributable to the reduc-
tion of the adsorbed quinone alone. The Qcat/QQ value of
UQ2 was 1.43, and is larger than that of DMQ2 ( = 1.16)
(Kano, unpublished data). This means that UQ2 is a stronger
catalyst than DMQ2 in terms of the O2 reduction into Oc32 . In
other words, UQ2 is more toxic than DMQ2 during the re-
duction under aerobic conditions.
Basically, the catalytic ability of quinones in the O2 reduc-
tion is governed by E‡P of quinones and the thermodynamic
stability of the semiquinone intermediate, as expressed by the
semiquinone formation constant K ( = [Qsem]2/[Qox][Qred]) ; the
more negative in E‡P and/or the larger in K, the more strongly
the Qred reduces O2 [48]. Interestingly, E‡P of DMQ2 is 17 mV
more negative than that of UQ2, in spite of lower catalytic
activity of DMQ2. Therefore, it might be expected that DMQ2
is smaller in K than UQ2.
5. Mechanism of life span extension in clk-1 mutants
The data in the previous section clearly indicate that,
although DMQ2 retains lower redox potential compared to
UQ2, the prooxidant action of DMQsem would be weaker
than UQsem. This property of DMQsem might lead to the
reduced production of ROS in clk-1 mutants, and conse-
quently, to the slow ageing phenotype.
In addition to the weaker prooxidative activity of DMQsem,
the slightly reduced respiration in clk-1 mutant mitochondria
may also contribute to the reduced ROS production.
Although the respiration of clk-1 mutant mitochondria mea-
sured in vitro was nearly at the wild-type level at complex I,
the respiration was slightly retarded when succinate was used
as substrate [14,49]. Since complex II is also an enzyme in
TCA cycle, the slower rate of electron transfer at complex
II in vivo may result in the reduction of the NADH/NAD
ratio, leading to the slower respiration from complex I. Sup-
porting this possibility is the slightly reduced oxygen con-
sumption in clk-1 mutants [22], as well as the lower metabolic
rate of daf-2, clk-1 double mutants compared to daf-2 mutant
[50]. Slower respiration may lead to a decreased transmem-
brane electric potential di¡erence (vi), which critically a¡ects
the rate of ROS generation via the generation of UQsem [51].
Taken together, it is likely that ROS generation in clk-1 mu-
tants might be reduced by the synergistic e¡ect of the less
prooxidative property of DMQ, and the reduced rate of res-
piration due to the change in structure and mid-point poten-
tial of quinones.
Despite the above considerations, some recent works pro-
vide an alternative point of view. For example, the analysis of
point mutations in the redox-active subunits of complex III
has suggested that lowering the rate of respiration and ROS
generation could not increase the life span of daf-2 mutants
that already have high ROS resistance [30]. This is in contrast
to what is observed with clk-1 mutations, which can more
than double the life span of daf-2 mutants [7]. We have also
recently shown that DMQ cannot e⁄ciently replace UQ at an
unidenti¢ed cellular site, distinct from the electron transport
chain [24,52]. It is possible therefore that the increased life
span of clk-1 mutants is due to the physiological consequences
of the replacement of UQ by DMQ at other cellular sites in
addition to the respiratory chain (see below).
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6. Function of CLK-1
The identi¢cation of DMQ9 in clk-1 mutants raised the
possibility that CLK-1 is critical in the biosynthesis of UQ9
from DMQ9. CLK-1 is localized in mitochondria [49], and its
homologs, yeast COQ7 and mouse mCLK1 localize in the
matrix side of the inner mitochondrial membrane [53,54].
The high degree of homology of clk-1/COQ7 between orga-
nisms [55] implied that the function of CLK-1/Coq7p might
be conserved throughout evolution. However, until recently,
its biochemical function had been unknown.
A recent report from Stenmark et al. [56] revealed that
bacterial clk-1/COQ7 homologs from Pseudomonas aeruginosa
and Thiobacillus ferrooxidans, are able to complement the UQ
de¢ciency of E. coli ubiF mutant, indicating that clk-1/COQ7
catalyze the monooxygenation of DMQ. It was also found
that clk-1/COQ7 genes contain the conserved -EXXE- motifs
of di-iron containing monooxygenase/hydroxylases [56].
Although this needs to be con¢rmed by further biochemical
analyses, these ¢ndings, together with the high conservation of
the primary structure of CLK-1/Coq7p between bacteria and
mitochondria [56], indicate that mitochondrial CLK-1/Coq7p
might also function as a hydroxylase. The -EXXE- motif has
also been identi¢ed in plants and trypanosome quinol-oxidase
(known as cyanide-insensitive alternative oxidase, AOX)
[57,58], that is also located on the matrix side of the inner
mitochondrial membrane [57]. Thus, it would be reasonable to
place CLK-1 and AOX within the family of di-iron enzymes,
which contain binding sites for both quinones and oxygen,
and play an important role in oxygen metabolism.
Interestingly, yeast Coq7p has been shown to play a regu-
latory or structural role in the UQ biosynthesis pathway, since
COQ7 is absolutely required for the functional expression of
Coq3p, which participates in several UQ biosynthesis steps
[59]. This possibility is also consistent with the fact that while
a yeast coq7 point mutant contains a small amount of DMQ6,
the coq7 deletion mutant does not contain DMQ6, but accu-
mulates 4-hydroxy-3-hexaprenylbenzoic acid (compound 1 in
Fig. 1) [60]. The ¢ndings that worm and mammalian clk-1/
COQ7 complement the respiratory de¢ciency of yeast coq7
deletion mutant [55,61] indicate that the regulatory function
of Coq7p might be retained in the multicellular CLK-1/Coq7p
proteins.
Finally, the multiple developmental and behavioral pheno-
types of clk-1 mutants raise the question of whether mito-
chondrial CLK-1/Coq7p participates solely in UQ biosynthe-
sis, or whether it has retained additional functions involved in
regulating these multiple phenotypes. UQ9 is equally undetect-
able in phenotypically weak (e2519) and strong (qm30 and
qm51) clk-1 alleles [14]. It suggests that either the UQ9 de¢-
ciency is not responsible for the clk-1 phenotype, or that very
low levels of UQ9 are made in e2519 mutants, and that such
levels are su⁄cient for some phenotypic relief. To further elu-
cidate the function of CLK-1 in higher eukaryotes, we have
recently created a mclk1 knockout in mice [24]. We found that
the homozygous mutants are UQ de¢cient, as is the case in
C. elegans. However, these homozygotes were embryonic le-
thal, despite the presence of large amounts of DMQ9 that
could partially (65%) support respiration. This ¢nding sug-
gests that UQ9, and/or mCLK1, may play an essential role
in the developmental process of mammals, in addition to its
functions in energy metabolism [24].
7. Conclusion
The identi¢cation of clk-1 mutants revealed that a change in
quinone species could alter metabolism and life span in eu-
karyotes, possibly via altering the rate of ROS generation in
mitochondria.
Besides its important role in respiration, recent data indi-
cate that UQ is an indispensable component in various bio-
logical machineries. For instance, UQ is used as signaling
molecule in the bacterial Arc two-component system, in which
UQox inhibits kinase activity of ArcB [62]. UQ also serves as
an electron acceptor in the bacterial Dsb system, which cata-
lyzes thioester bond formation [63]. In eukaryotes, UQ is an
activator of uncoupling protein, which regulates the mem-
brane potential and the rate of ATP synthesis in mitochondria
[64]. Furthermore, there is evidence now, both in worms [52]
and in mice [24], that DMQ cannot functionally replace UQ
for at least one of these functions. Given this, it is possible
that life span extension in clk-1 mutants is the result of the
alteration of one or more UQ-dependent processes.
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